[Skip to Content]
[Skip to Content Landing]
Article
July 24, 1995

Liposomal Amphotericin B Therapy in Disseminated Histoplasmosis

Author Affiliations

Kiel, Germany

Arch Intern Med. 1995;155(14):1556. doi:10.1001/archinte.1995.00430140136020
Abstract

The incidence of disseminated histoplasmosis in the United States is increasing, especially among immunocompromised patients.1 Conventional treatment consists of amphotericin B, whose

×